Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation

Hajime Yoshida, Kuniaki Okamoto, Tsutomu Iwamoto, Eiko Sakai, Kazuhiro Kanaoka, Jin Ping Hu, Mitsue Shibata, Hitoshi Hotokezaka, Kazuhisa Nishishita, Akio Mizuno, Yuzo Kato

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Pepstatin A is well known to be an inhibitor of aspartic proteinases such as pepsin, cathepsins D and E. Except for its role as a proteinase inhibitor, however, the pharmacological action of pepstatin A upon cells remain unclear. In this study, we found that pepstatin A suppressed receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation. Pepstatin A suppressed the formation of multinuclear osteoclasts dose-dependently. This inhibition of the formation only affected osteoclast cells, i.e., not osteoblast-like cells. Furthermore, pepstatin A also suppressed differentiation from pre-osteoclast cells to mononuclear osteoclast cells dose-dependently. This inhibition seems to be independent of the activities of proteinases such as cathepsin D, because the formation of osteoclasts was not suppressed with the concentration that inhibited the activity of cathepsin D. Cell signaling analysis indicated that the phosphorylation of ERK was inhibited in pepstatin A-treated cells, while the phosphorylation of IκB and Akt showed almost no change. Furthermore, pepstatin A decreased the expression of nuclear factor of activated T cells c1 (NFATc1). These results suggest that pepstatin A suppresses the differentiation of osteoclasts through the blockade of ERK signaling and the inhibition of NFATc1 expression.

Original languageEnglish
Pages (from-to)583-590
Number of pages8
JournalJournal of biochemistry
Volume139
Issue number3
DOIs
Publication statusPublished - Mar 1 2006
Externally publishedYes

Keywords

  • Aspartic proteinase
  • Cathepsin
  • Osteoclast
  • Pepstatin A

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Fingerprint Dive into the research topics of 'Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation'. Together they form a unique fingerprint.

  • Cite this

    Yoshida, H., Okamoto, K., Iwamoto, T., Sakai, E., Kanaoka, K., Hu, J. P., Shibata, M., Hotokezaka, H., Nishishita, K., Mizuno, A., & Kato, Y. (2006). Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. Journal of biochemistry, 139(3), 583-590. https://doi.org/10.1093/jb/mvj066